Ketu Medicine uses PDO organoid technology to help precision tumor treatment.
Business Model:
Revenue: $0
Employees: 51-200
Address:
City: Beijing
State: Beijing
Zip:
Country: China
Ketu Medicine was established in August 2016 by Dr. Sun Zhijian, former senior researcher of BeiGene, Mr. Kang Ping, former co-founder of ACROBiosystems, and Professor Xie Dong, professor/chief scientist of the Institute of Nutrition, Chinese Academy of Sciences. founded. Ketu Medicine is the earliest domestic company focusing on the research and development and commercial transformation of organoid technology. The core team members have served in well-known pharmaceutical companies, hospitals, scientific research and CROs such as Novartis, BeiGene, GE Healthcare, Chinese Academy of Sciences, 301 Hospital, etc. service organization.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2022 | Series B | 1 | - |
FOF Capital FOF Capital |
1/2016 | Venture Round | 1 | - |
Tengye Ventures Tengye Ventures |
8/2022 | Series B | 1 | - |
FOF Capital FOF Capital |
1/2016 | Venture Round | 1 | - |
Tengye Ventures Tengye Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|